Middle-aged woman viewing MRI brain scan showing menopause-related grey matter reduction in memory and emotion regions, with symbolic anxiety and sleep icons.
Middle-aged woman viewing MRI brain scan showing menopause-related grey matter reduction in memory and emotion regions, with symbolic anxiety and sleep icons.
Bilde generert av AI

Study links menopause to reduced grey matter in memory and emotion-related brain regions

Bilde generert av AI
Faktasjekket

A large University of Cambridge analysis of UK Biobank data found that post-menopausal women showed smaller grey matter volumes in several brain regions tied to memory and emotional regulation, alongside higher reported anxiety, depression and sleep difficulties. Hormone replacement therapy (HRT) was not associated with preventing these differences, although it was linked with a slower decline in reaction speed.

Researchers at the University of Cambridge analyzed UK Biobank data from nearly 125,000 women to examine associations between menopause, hormone replacement therapy (HRT), mental health, sleep, cognition and brain structure.

Participants were grouped as: women who had not yet reached menopause, post-menopausal women who had never used HRT, and post-menopausal women who had used HRT. The average age at menopause in the dataset was about 49.5 years, and women prescribed HRT typically began treatment at around age 49.

Across questionnaire measures, post-menopausal women were more likely than pre-menopausal women to report seeking help from a GP or psychiatrist for anxiety, nervousness or depression. They also scored higher on depression questionnaires and were more likely to have been prescribed antidepressant medication. Women in the HRT group reported higher levels of anxiety and depression than post-menopausal women who did not use HRT, but additional analyses indicated these differences were already present before menopause began, suggesting HRT may have been prescribed in some cases where symptoms were already emerging.

Sleep problems were also reported more often after menopause, including insomnia, reduced sleep and persistent tiredness. Women using HRT reported the highest levels of fatigue, even though their total sleep duration did not differ from post-menopausal women who were not taking HRT.

On cognitive testing, memory performance did not differ significantly across the three groups. Reaction time, however, was slower in post-menopausal women who were not using HRT compared with women who had not yet reached menopause and post-menopausal women who were using HRT.

In a subset of roughly 11,000 women who underwent MRI brain scanning, researchers found smaller grey matter volumes in post-menopausal women in regions including the hippocampus, entorhinal cortex and anterior cingulate cortex. These differences were observed regardless of whether women had used HRT.

Dr. Christelle Langley, from the University of Cambridge Department of Psychiatry, said menopause can be “life-changing” and argued that lifestyle measures such as staying active and eating a healthy diet are particularly important during this period. Dr. Katharina Zühlsdorff, from the university’s Department of Psychology, said reaction times typically slow with age, adding that menopause appeared to accelerate this slowing, while HRT “appears to put the brakes on” slightly.

Professor Barbara Sahakian, the senior author, said the brain regions showing differences are among those affected in Alzheimer’s disease, and suggested the findings may offer one possible clue toward why dementia is more common in women than in men, while emphasizing this would not be the only factor.

The study was published in the journal Psychological Medicine.

Hva folk sier

X discussions acknowledge the Cambridge/UK Biobank study linking post-menopause grey matter loss in memory and emotion brain regions to increased anxiety, depression, and sleep issues, with HRT slowing but not preventing changes. Reactions validate symptoms like brain fog, stress lifestyle interventions, express dementia concerns, and include skeptical views on extrapolating to gender hormone effects.

Relaterte artikler

Illustration of a woman with depression symptoms overlaid with microscopic view of aging monocytes in blood, linking to study on women with and without HIV.
Bilde generert av AI

Study links monocyte “biological aging” in blood to emotional depression symptoms in women with and without HIV

Rapportert av AI Bilde generert av AI Faktasjekket

A study of 440 participants from the Women’s Interagency HIV Study found that accelerated epigenetic aging in monocytes—an immune cell type—tracked more closely with emotional and cognitive depression symptoms such as hopelessness and loss of pleasure than with physical symptoms like fatigue. The work, published in The Journals of Gerontology: Series A, adds evidence that cell-type-specific aging measures could contribute to future biological tools to complement symptom-based depression screening, though researchers say more validation is needed before clinical use.

New research from the University of California San Diego shows that several common dementia risk factors affect women's cognitive performance more strongly than men's. The findings help explain why women account for nearly two thirds of Alzheimer's cases in the United States.

Rapportert av AI

New research indicates that oestrogen levels, which vary across the menstrual cycle, can influence how efficiently some drugs reach the brain in women.

Dette nettstedet bruker informasjonskapsler

Vi bruker informasjonskapsler for analyse for å forbedre nettstedet vårt. Les vår personvernerklæring for mer informasjon.
Avvis